Publications

29 Oct 2010
News

The Mental Game of Breast Cancer

December 2009 (Revised May 2012)
Case

Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan

By: Michael E. Porter, Jennifer F Baron and C. Jason Wang

Taiwan's Koo Foundation Sun Yat-Sen Cancer Center has developed an integrated, team-based care delivery model for breast cancer care that is being expanded to other cancer types in 2009. A decade earlier, President and CEO Dr. Andrew Huang and the Center had worked... View Details

Keywords: Health Care and Treatment; Medical Specialties; Service Delivery; Outcome or Result; Performance Effectiveness; Quality; Integration; Health Industry; Insurance Industry; Taiwan

2024
Working Paper

Tamoxifen—Reducing Breast Cancer Risks: Case Histories of Transformational Advances

By: Amar Bhidé, Srikant Datar and Katherine Stebbins

We describe the development of tamoxifen, considered a “gold standard” treatment for millions of breast cancer patients. Specifically, we describe breast cancer treatments before tamoxifen’s development; the initial development of tamoxifen from 1960 to 1973;... View Details

Keywords: Health Care and Treatment; Technological Innovation; Innovation and Invention; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Governing Rules, Regulations, and Reforms

SSRN

Read Now

Article

Time-Driven Activity-Based Costing in Breast Cancer Care Delivery

By: Navraj S. Nagra, Elena Tsangaris, Jessica Means, Michael J. Hassett, Laura S. Dominici, Jennifer R. Bellon, Justin Broyles, Robert S. Kaplan, Thomas W. Feeley and Andrea L. Pusic

We used time-driven activity-based costing (TDABC) to calculate the complete cost of breast cancer care—initial treatment planning, chemotherapy, radiation therapy, surgical resection and reconstruction, and ancillary services (psychosocial oncology, physical therapy.... View Details

Keywords: Healthcare; Time-Driven Activity-Based Costing; Health Care and Treatment; Cost

Find at Harvard

July 2011 (Revised September 2012)
Case

Intraoperative Radiotherapy for Breast Cancer (A)

By: Willy Shih

"This trial is going to take longer." Those were words that Michael Kaschke, CEO of Carl Zeiss AG, was not surprised to hear as he nurtured the intraoperative radiotherapy business inside his company's microsurgery unit. But he also didn't expect it to take 13 years to... View Details

Keywords: Finance; Business History; Disruptive Innovation; Emerging Markets; Organizational Change and Adaptation; Research and Development; Safety

September–October 2023
Article

Prospective Evaluation of the Cost of Performing Breast Imaging Examinations Using Time-Driven Activity-Based Costing Method: A Single Center Study

By: Aamir Ali, Jordana Phillips, Damir Ljuboja, Syed S. Shehab, Etta D. Pisano, Robert S. Kaplan and Ammar Sarwar

We use time-driven activity-based costing (TDABC) to measure the cost of performing breast imaging using different modalities: full-field digital mammography (FFDM), digital breast tomosynthesis (DBT), contrast-enhanced mammography (CEM), US and MRI exams, and... View Details

Keywords: Time-Driven Activity-Based Costing; Health Care; Breast Cancer; Health Care and Treatment; Cost; Cost Accounting; Health Industry

Read Now

August 2016
Article

Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes

By: Fayanju M. Oluwadamilola, Tinisha L. Mayo, Tracy E. Spinks, Seohyun Lee, Carlos H. Barcenas, Benjamin D. Smith, Sharon H. Giordano, Rosa F. Hwang, Richard A. Ehlers, Jesse C. Selber, Ronald Walters, Debu Tripathy, Kelly K. Hunt, Thomas A. Buchholz, Thomas W. Feeley and Henry M. Kuerer

Purpose. Value in healthcare—i.e., patient-centered outcomes achieved per healthcare dollar spent—can define quality and unify performance improvement goals with health outcomes of importance to patients across the entire cycle of care. We describe the process... View Details

Keywords: Health Disorders; Value; Health Care and Treatment; Performance Improvement; Health Industry

Find at Harvard

January 2023
Teaching Note

Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care

By: Robert S. Kaplan

This Teaching Note was prepared to aid classroom instructors in the use of "Brigham and Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care," HBS Case No. 122-010. View Details

January 2014 (Revised March 2014)
Case

Cancer Screening in Japan: Market Research and Segmentation

By: John A. Quelch and Margaret L. Rodriguez

Since founding CancerScan in 2008, Jun Fukuyoshi and Yoshiki Ishikawa had helped to improve cancer screening rates in Japan. Between 2005 and 2007, awareness of breast cancer in Japan rose from 55% to 70%, but the incidence of breast cancer screenings remained... View Details

Keywords: Cancer; Public Health Projects; Japan; Japan

February 2010
Teaching Note

Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan (TN)

By: Michael E. Porter and Jennifer F Baron

Teaching Note for [710425]. View Details

Keywords: Health Care and Treatment; Strategy; Service Delivery; Quality; Performance; Insurance; Growth and Development; Health Industry; Taiwan

July 2021 (Revised July 2022)
Case

Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care

By: Robert S. Kaplan, Navraj S. Nagra and Syed S. Shehab

Dr. Andrea Pusic, breast cancer reconstruction surgeon, wants to extend outcomes measurement beyond traditional surgical metrics of infections, complications, and survival rates. The case describes her development of a new mobile phone app, which collects patients’... View Details

Keywords: Health Care and Treatment; Outcome or Result; Cost Management; Activity Based Costing and Management; Mobile and Wireless Technology; Health Testing and Trials; Surveys; Health Industry; Boston

01 Nov 2010
News

The Mental Game of Breast Cancer: Part Two

November 2020 (Revised May 2021)
Technical Note

Tales of Life-changing Innovations: Reducing Breast Cancer Risks | Note on the Development of Tamoxifen (through 1999)

By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins

14 May 2018
News

HBS Kraft Precision Medicine Accelerator Brings Together Five Leading Cancer Organizations to Engage Patients and Accelerate Precision Medicine across Cancers

22 Feb 2024
News

Combat-Tested Cancer Coaching

Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details

01 Apr 2015
Research & Ideas

The Slow, Steady Battle to Fix Cancer Care

of things that mattered to patients that weren't necessarily the kinds of things that we as clinicians thought about. This was a new idea to us, this idea that, gee, cancer patients aren't always primarily interested in a cure. At least,... View Details

Keywords: by Carmen Nobel; Health

21 Oct 2015
News

Mammogram Guidelines, Legal Caucus & A New Greater Bostonian

August 2011 (Revised September 2011)
Supplement

The Dannon Company: Marketing and Corporate Social Responsibility (B)

By: Christopher Marquis and Bobbi Thomason

Details Dannon's decision to initiate a cause marketing program focused on breast cancer to directly compete with Yoplait. View Details

Keywords: Marketing; Corporate Social Responsibility and Impact; Food and Beverage Industry

February 2023
Supplement

Dr. Andrea Pusic, Video Supplement

By: Robert S. Kaplan

Video supplement to aid in the teaching of "Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care," HBS case no. 122-010. View Details